Menu

 

Letter

Inhaled corticosteroids for COPD

Risk-benefit profile of inhaled corticosteroids in COPD is still unclear

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8360 (Published 20 December 2012)
Cite this as: BMJ 2012;345:e8360

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ricky D Turgeon, pharmacy resident1,
  2. Aaron M Tejani, researcher2
  1. 1Lower Mainland Pharmacy Services, Vancouver, BC, Canada V5Z 1M9
  2. 2Therapeutics Initiative (UBC), Vancouver, BC, Canada
  1. ricky.turgeon{at}vch.ca

Park and colleagues’ review acknowledges the harms associated with using inhaled corticosteroids for chronic obstructive pulmonary disease (COPD).1 To help clinicians make informed decisions, we wish to clarify the absolute benefits and harms.

Estimates of benefit were less optimistic in an up-to-date and comprehensive Cochrane review,2 partly because of Park and colleagues’ unconventional derivation of the number needed …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Subscribe

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls